Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Achillion Pharmaceuticals Inc (ACHN)  
$6.16 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 137,858,000
Market Cap: 849.21(M)
Last Volume: 3,159,761 Avg Vol: 1,438,163
52 Week Range: $6.16 - $6.16
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Achison engages only in internet advertising through www.dazhong368.com in the New York area.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 389
  Page 16 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Advent Partners Hls Ii Limited Partnership Member of group no longer >10%   –       –      –    2006-10-31 4 A $0.00 $0 D/D 22,326 22,326     -
   Advent International Corp Member of group no longer >10%   –       –      –    2006-10-31 4 A $0.00 $0 I/I 1,116,432 1,116,432     -
   Sitco Nominees Ltd. Vc 01903 As Nominee Of Schrode 10% Owner   –       –       •   2006-10-31 4 A $0.00 $0 I/I 1,710,231 1,710,231     -
   Atlas Venture Associates V Lp 10% Owner   –       –       •   2006-10-31 4 A $0.00 $0 I/I 1,968,670 1,968,670     -
   Formela Jean Francois Director   –       •       •   2006-10-31 4 A $0.00 $0 I/I 1,968,670 1,968,670     -
   Scheer David Director   –       •      –    2006-10-31 4 A $0.00 $0 I/I 2,939 63,249     -
   White Christopher A Director   –       •      –    2006-10-31 4 A $0.00 $0 I/I 922,451 922,451     -
   White Christopher A Director   –       •      –    2006-10-31 4 A $0.00 $0 D/D 2,242 2,242     -
   Ryser Stefan Director   –       •      –    2006-10-31 4 A $0.00 $0 I/I 979,901 979,901     -
   Gilead Sciences Inc 10% Owner   –       –       •   2006-10-31 4 A $0.00 $0 D/D 1,115,839 1,115,839     -
   Fenton Mary Kay Vice President and CFOOfficer   •       –      –    2006-10-25 3 IO $0.00 $0 D/D 0 17,000     -
   Pottage John C Jr SVP and Chief Medical OfficerO   •       –      –    2006-10-25 3 IO $0.00 $0 D/D 0 12,500     -
   Deshpande Milind SVP and Chief Scientific Ofc.O   •       –      –    2006-10-25 3 IO $0.00 $0 D/D 0 15,625     -
   Scheer David Director   –       •      –    2006-10-25 3 IO $0.00 $0 I/I 0 60,310     -

  389 Records found
  Previous  10  11  12  13  14  15  16    
  Page 16 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed